It is commonly assumed that loss of responsiveness and recovery of responsiveness occur at similar concentrations of propofol. However, the 'conscious' and 'anaesthetised' conditions produced by general anaesthetics may behave as two bistable states. We hypothesised that loss of responsiveness and recovery of responsiveness occur at different propofol concentrations. Propofol was administered to 19 healthy volunteers by effect-site target-controlled infusion using increasing and decreasing stable concentration steps of 7 min. Propofol serum concentrations were measured from venous blood samples at the end of each 7-min step. A long step of 14 min was performed at loss of responsiveness. At this step, propofol concentrations were measured at 7 and 14 min. Propofol concentrations measured at loss of responsiveness and recovery of responsiveness were 2.6 (1.2-4.7) lg.ml À1 and 1.6 (0.6-3.3) lg.ml
Introduction
Loss of responsiveness (LOR) and recovery of responsiveness (ROR) are assumed to occur at similar anaesthetic drug concentrations [1] . Physiological evidence, however, suggests that the 'loss and recovery' phenomenon involves a more complex neuronal response which cannot be completely explained by this assumption. Studies in drosophila and rats [2, 3] have shown that calculated cerebral concentration of inhalational agents required for induction of anaesthesia is higher than for emergence. It has been hypothesised that these discrepancies reflect an inherent central nervous system property characterised by a resistance to change between bistable states of consciousness and unconsciousness, which has been called neuronal inertia [2] .
Target-controlled infusion (TCI) is a technique to administer intravenous anaesthetics in which a pharmacokinetic (PK) model is incorporated into a computer-controlled infusion pump allowing rapid achievement and maintenance of drug concentrations, either in plasma (Cp) or the effect-site (Ce). During propofol TCI, it is commonly seen that effect-site concentrations required for induction of anaesthesia are higher than those seen at emergence. Although this observation might suggest the presence of neural inertia, it is also possible that the predicted propofol concentrations at the effect-site might not be accurate, especially during induction of anaesthesia, where PK model mis-specifications are often observed [4, 5] .
The aim of this study was to compare propofol concentrations at LOR and ROR during stable conditions obtained using a TCI administration scheme characterised by small-step (0.5 lg.ml
À1
) increments and decrements of propofol Ce using the original Schnider PK model. We hypothesised that LOR occurs at higher concentrations than ROR and, therefore, both represent different states of consciousness.
Methods
After institutional review board approval and with written informed consent, we recruited healthy volunteers to participate in this study. Baseline data were recorded after a period of 2 min while the patients were undisturbed with their eyes closed. Propofol infusion was then started with an initial Ce target of 0.5 lg.ml À1 for 7 min. The Ce target was increased in 0.5 lg.ml À1 steps every 7 min until LOR. In the step where LOR occurred, the target Ce was maintained for 14 min to ensure stable conditions. Two additional incremental steps were performed after LOR in order to be able to observe the recovery phase from a deeper hypnotic level. Thereafter, 7-min decremental Ce steps of 0.5 lg.ml À1 were performed until ROR. Loss of responsiveness was defined as loss of response (eye opening and/or verbal response) when calling the volunteer by his/her name in a loud voice. Similarly, ROR was defined as return of response (eye opening and/or verbal response) to verbal command and was assessed at the end of each 7-min decrement step. The same three investigators (PS, EC and MR) performed all assessments; none of them was blind to propofol concentrations. To consider a positive response for LOR and ROR, the three assessors had to agree.
To assess whether Cp measurements taken at the end of each 7-min step were obtained during stable conditions and, therefore, can adequately represent propofol concentration at the effect-site (Ce), we used several approaches: (1) we compared blood samples taken at minutes 7 and 14 at the point of LOR; (2) we compared simultaneous propofol arterial and venous samples in five volunteers; and (3) we assessed the performance of the Schnider PK model. Accuracy and bias of model predictions were calculated and reported as described by Varvel et al. [7] . Median prediction error (MDPE) represents the median bias of the model. The median absolute performance error (MDAPE) represents the median accuracy of the prediction. To obtain the population MDPE and MDAPE, we first calculated the performance error (PE) for each observed and predicted value in each individual patient according to the formula:
Median absolute performance error and MDPE were obtained with the following:
An acceptable performance is generally considered as a MDPE less than 20% and MDAPE between 20% and 40% [8] .
Blood samples of 4 ml were obtained from a vein in the contralateral arm every 7 min at the end of each step, before modifying the TCI target. Samples were stored in ice and centrifuged within 1 h. Plasma obtained from centrifugation was stored at À20°C for later determination of propofol concentration. Propofol concentrations were measured using a previously reported high-pressure liquid chromatography method [9] . Thymol was added as internal standard to each sample to allow correction of errors occurring during sample pre-treatment steps. Samples were cleaned using a solid phase extraction technique. The calibration curve (relationship between propofol concentrations in calibration standards and the chromatographic signals measured) was linear in the 0.1-20 lg.ml À1 range when evaluated with the ANOVA lack-of-fit test (p = 0.405) and through the coefficient of correlation: r 2 = 0.9982.
This validated the linear model used to quantify samples with unknown concentrations of propofol. The limit of quantification was 0.1 lg.ml À1 (coefficient of variation
[CV] 7.76%). During analysis, the interday precision and accuracy were determined at three concentration levels: 0.25 lg.ml À1 , 5 lg.ml À1 and 15 lg.ml À1 giving the following results CV 8.3; 8.5% and 6.6% and accuracy 94%, 99% and 96%, respectively. We arbitrarily estimated a priori that a 30% difference between propofol concentration at LOR and ROR would be a clinically relevant difference. Assuming a theoretical propofol concentration at LOR and ROR of 2 lg.ml À1 and a SD of the difference of 0.7 lg.ml
À1
, we estimated that 13 subjects would be needed using a paired t-test sample calculator (power of 80%; alpha of 0.05). We recruited a total of 19 subjects because, after studying the first 14 subjects, we recruited five additional subjects to assess whether venous Cp measurements taken at the end of each 7-min step were similar to arterial measurements.
General data were tested for normality using the Shapiro-Wilk test. Comparisons between induction and recovery concentrations were performed using paired Student 0 s t-test or Wilcoxon signed rank-test according to their distribution. A p value ≤ 0.05 was considered statistically significant.
Results
Nineteen volunteers were studied. Recovery of data from one subject (measured propofol concentrations) was not possible due to loss of intravascular access. Baseline characteristics and general data are presented in Table 1 . A total of 235 venous blood samples were obtained and analysed. Time profiles of measured propofol plasma concentration are shown in Fig 1. The observed number of unresponsive subjects during the increasing and decreasing propofol concentration steps is shown in Fig 2. Measured plasma propofol concentration at LOR and ROR were 2.6 (1.2-4.7) lg.ml À1 and 1.6 (0.6-3.3) lg.ml
À1
, respectively (p < 0.001). There was no disagreement between observers regarding the step where LOR and ROR occurred. Table 2 shows the calculated vs. measured propofol Cp at LOR and ROR.
The population MDPE and MDAPE of the Schnider PK model were À0.5% and 26%, respectively. Predictive errors at each concentration step are shown in Table 3 .
Propofol Cp and the corresponding mean (SD) BIS values measured at minute 7 and minute 14 of the long step performed at LOR were LOR minute 7: 2.59, (0.96) vs. minute 14: 2.58 (0.92) lg.ml
, p = 0.96, and BIS at LOR minute 7: 61.24 (7.79) vs minute 14: 58.15 (7.92), p = 0.058, respectively.
Fifty-seven pairs of arterial and venous samples were analysed. The mean (SD) gradient between arterial and venous plasma concentration of propofol was 22% (93%). This gradient was stable after the first 15 min of the study with no evident influence from the study phase (Fig. 3) .
Discussion
The main result of this study is that LOR occurred at higher propofol concentrations than ROR. Although, this difference might support the possibility of neuronal inertia in transitions between LOR and ROR, this interpretation relies on having obtained complete equilibration between plasma concentration and effectsite concentration of propofol. Since we have assumed equilibration based on the Schnider effect-site model, it is possible that complete equilibration did not occur at the end of each 7-min step and, therefore, differences in propofol concentrations at LOR and ROR could reflect biased predictions due to the relatively fast ke0 incorporated in the Schnider model. This has been a criticism of the Schnider PK model [4, 10, 11] .
A recent study by Friedman et al. in mice found that isoflurane and halothane concentrations measured in the brain were higher during induction than emergence from anaesthesia [2] . In their study, using the righting reflex as a surrogate marker of consciousness, the authors reported higher anaesthetic requirements during induction than recovery from anaesthesia. Afterwards, in the same paper, they experimented in drosophila, using stepwise increasing and decreasing concentrations of an anaesthetic in air, and confirmed that induction of anaesthesia (absence of movement) occurred at higher concentrations than emergence (resumption of movement). A resistance to change between the 'conscious' and the 'anesthetised' state, which has been called 'neuronal inertia' or 'pharmacodynamic hysteresis', has been suggested as a probable explanation for these results. Using functional magnetic resonance imaging and EEG in rats, Hwang et al. concluded that sensory and motor-related thalamocortical networks behave discontinuously at anaesthesia induction and emergence [12] . The hyperpolarisation curve, as a function of anaesthetic concentration, demonstrates a hysteresis loop, with a Table 3 Performance analysis of the Schnider pharmacokinetic model expressed as median performance error (MDPE) and median absolute performance error (MDAPE). Data are presented disaggregated step by step.
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significantly higher anaesthetic level for transition to the down state (hyperpolarised mode -unconscious) compared with transition to the up state (depolarisation mode -conscious). In neuronal models, unconsciousness and consciousness are usually described as two bistable states [13] . Bistable dynamics implicate the tendency of a system to maintain its current state when facing small or random changes. As also seen with sleep and wakefulness, the 'conscious' and 'anesthetised' states during administration of an anaesthetic drug may behave in a bistable manner, with induction and emergence occurring at different drug concentrations (pharmacodynamic hysteresis) due to bistability between up and down states in thalamocortical circuits [14] . Mathematical models of bistable systems also predict the existence of hysteresis during the transition between two existing stable states [2, 13, 15] . These systems are very frequent in biology and the described barrier is understood as a defence mechanism to avoid major neuronal responses to small environmental perturbations [13] . Most pharmacodynamic studies characterising propofol concentration-effect relationship have been performed under conditions of non-equilibrium, using either boluses or fast infusion schemes [6, [16] [17] [18] . In these types of studies, the concentration-effect relationship is characterised using effect-site models which predict the concentration of the drug at the site of effect to cope with the hysteresis between concentration and response [5, 19] . This approach normally assumes a single curve to characterise the entire concentration-effect relationship, ignoring possible path dependencies of the transitions to and from unconscious states. In contrast, our protocol consisted of up and down stable Ce steps where measured plasma propofol concentrations were directly linked to drug response to avoid possible PK model misspecifications. However, despite the 7-min steps between changes in Ce, our protocol design cannot guarantee complete equilibration between Cp and Ce. Although the Schnider model showed a good performance in Cp predictions, it is possible that plasma effect-site equilibration was not reached due to the relatively fast ke0 (0.45 min
À1
) incorporated in this model. In support of having reached stable conditions during Cp measurements we found that the PK performance of the Schnider PK model was good, (MDPE = À0.5% and MDAPE = 26%). In addition, we found stable arterialvenous differences throughout the study period and stable measured propofol Cp and BIS at minute 7 and minute 14 of the long step. Furthermore, propofol Cp estimated at LOR were in accordance with previously reported values [20, 21] . While, as stated by Cort ınez [5] , blood measurements provide no guide to equilibration between the blood and effect-site concentrations, the relatively stable BIS values observed at minute 7 and 14 of the long step (61.2 (49-77) vs. 58.4 (45-74)) do suggest that propofol concentrations were relatively stable at the effect-site (Fig. 4) . Arguments against having reached plasma effect-site equilibration with the , there is an increasing risk of incomplete equilibration between Cp and Ce at the end of a 7-min step. If this is the case, measured Cp at the end of each step will over estimate Ce during increasing steps and the opposite will occur during decreasing steps. current protocol design come from different studies. Barakat et al. showed that changes in the sedation score assessed by the Observer Assessment of Alertness/Sedation score (OAAS) and bispectral index correlated better with the slower effect-site equilibration time predicted by the Marsh than by the Schnider model [22] . Their study showed that equilibration took about 15 min based on BIS response data. Similarly, Sep ulveda et al. [23] and Doufas et al. [20] [25] , showed that both the Schnider model with a 'fast' ke0 and the Marsh model with a 'slow' ke0 of 0.26 min À1 failed to maintain a constant hypnotic effect over time, confirming the limitations of current effect-site models. In Coppens study, using a 300 ml.h À1 infusion rate until LOR, the BIS continued to decline for 11 min after LOR despite maintaining a constant target with the Schnider model. The apparent discrepancy with our study might be explained by the slower induction steps that we performed.
Previous studies have shown a wide disparity in propofol effect-site equilibration rates depending on numerous variables like speed of infusion, the modelling method, the type of effect measured, patient characteristics etc. [5, 16, [24] [25] [26] . In our study, if plasma effect-site equilibration was not accomplished at the end of each 7-min step, the higher concentrations found at loss of LOR compared with those observed during ROR can be explained by a bias in Ce estimations of the Schnider model and not by neural inertia. This limitation is illustrated in Fig. 5 . Based on the uncertainty of having reached equilibrium conditions, our study data are not enough to confirm neural inertia under propofol anaesthesia.
When performing propofol TCI with the Schnider model, it is commonly observed that the concentrations necessary for the induction of anaesthesia are higher than those observed on recovery of consciousness. Based on current evidence, this observation is probably due to model mis-specifications due to a fast ke0 and not by neural inertia. Although this study is probably closer to the 'real' equilibration time than previous studies, more research is needed to further explore neurobiological data about biostability of neural systems and its relevance in the clinical scenario.
In conclusion, we have observed that LOR occurred at a higher propofol concentration than ROR through a protocol design consisting of sequential up and down Ce steps performed with the Schnider effect-site model. Our results, although suggestive of, cannot definitively confirm the presence of neuronal inertia in transitions between LOR and ROR, since it is possible that incomplete equilibration between propofol Cp and Ce, from the fast ke0 included in Schnider model, can explain our results.
